Guideline Updates G21: KDIGO 2024 CKD Guideline: When to Use SGLT2 Inhibitors

The 2024 KDIGO CKD guideline gives a tiered SGLT2 inhibitor recommendation, strong for type 2 diabetes with CKD, strong for heavy albuminuria or heart failure regardless of diabetes, and a weaker suggestion for low-albuminuria low-eGFR disease, not a blanket recommendation for all CKD